727
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Ticagrelor: the first novel reversible P2Y12 inhibitor

&
Pages 237-245 | Published online: 27 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yao Yang, Joshua P Lewis, Jean-Sébastien Hulot & Stuart A Scott. (2015) The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19. Expert Opinion on Drug Metabolism & Toxicology 11:10, pages 1599-1617.
Read now
Stuart A Scott, Aniwaa Owusu Obeng & Jean-Sébastien Hulot. (2014) Antiplatelet drug interactions with proton pump inhibitors. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 175-189.
Read now

Articles from other publishers (10)

Matteo CastrichiniJasmine A. Luzum & Naveen Pereira. (2023) Pharmacogenetics of Antiplatelet Therapy. Annual Review of Pharmacology and Toxicology 63:1, pages 211-229.
Crossref
Pierre Giguère, Salin Nhean, Alice L. Tseng, Christine A. Hughes & Jonathan B. Angel. (2019) Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications. Canadian Journal of Cardiology 35:3, pages 326-340.
Crossref
Bin Wu, Ruoyan Gai Tobe, Yuchen Liu & Ben He. (2018) Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries. Clinical Drug Investigation 38:7, pages 621-630.
Crossref
Bin Wu, Houwen Lin, Ruoyan Gai Tobe, Le Zhang & Ben He. (2018) Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials. Journal of Comparative Effectiveness Research 7:3, pages 281-291.
Crossref
Lauren R. Cirrincione & Kimberly K. Scarsi. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions 297 356 .
Qiutong Tan, Xin Jiang, Sichao Huang, Tiantian Zhang, Lin Chen, Siwen Xie, Enpan Mo, Jun Xu & Shaohui Cai. (2017) The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis. PLOS ONE 12:5, pages e0177872.
Crossref
Larisa H. Cavallari & Aniwaa Owusu Obeng. (2017) Genetic Determinants of P2Y12 Inhibitors and Clinical Implications. Interventional Cardiology Clinics 6:1, pages 141-149.
Crossref
Gregory Egan, Christine A. Hughes & Margaret L. Ackman. (2014) Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications. Annals of Pharmacotherapy 48:6, pages 734-740.
Crossref
Marc P. Bonaca, Deepak L. Bhatt, Eugene Braunwald, Marc Cohen, Philippe Gabriel Steg, Robert F. Storey, Peter Held, Eva C. Jensen & Marc S. Sabatine. (2014) Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. American Heart Journal 167:4, pages 437-444.e5.
Crossref
Pablo Avanzas, Cesar Morís & Peter Clemmensen. 2014. Pharmacological Treatment of Acute Coronary Syndromes. Pharmacological Treatment of Acute Coronary Syndromes 31 57 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.